Pieris received a grant of $17 million from the Bavarian Ministry of Economic Affairs for a drug to treat lung scarring in COVID sufferers. Shares of Pieris Pharmaceuticals (PIRS) jumped on Friday ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have ...

The long-term effects of respiratory viral infections such as COVID-19 are a major public health burden. Some estimates suggest over 65 million people around the world suffer from long COVID-19.

he most common type of lung fibrosis — scarring of the lungs -- is idiopathic, meaning of unknown cause. Researchers are urgently trying to find ways to prevent or slow idiopathic pulmonary fibrosis ...

Investigators involved in a multicenter study co-led by Cedars-Sinai discovered a pathway by which immune cells prevent the lungs’ protective barrier from healing after viral infections like COVID-19.

TAMPA, Fla — Most of the patients doctors are seeing in the hospital now are critical. They need help breathing because of the damage COVID-19 is causing to their lungs. "It's been all hands on deck.

UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease (ILD), an increasingly common condition that is a leading reason for lung ...

Researchers have discovered a pathway by which immune cells prevent the lungs' protective barrier from healing after viral infections like COVID-19. Investigators involved in a multicenter study ...